Cargando…

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study

Background: Is it well-known that one of the major drawbacks of Lupus Anticoagulant (LA) test is their sensitivity to anticoagulant therapy, due to the coagulation based principle. In this study we aimed to assess the reproducibility of LA testing and to evaluate the performance of solid assay phosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sciascia, Savino, Radin, Massimo, Cecchi, Irene, Rubini, Elena, Scotta, Anna, Rolla, Roberta, Montaruli, Barbara, Pergolini, Patrizia, Mengozzi, Giulio, Muccini, Emanuela, Baldovino, Simone, Ferro, Michela, Vaccarino, Antonella, Mahler, Michael, Menegatti, Elisa, Roccatello, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411647/ https://www.ncbi.nlm.nih.gov/pubmed/30891041 http://dx.doi.org/10.3389/fimmu.2019.00376

Ejemplares similares

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies
por: Radin, Massimo, et al.
Publicado: (2020)

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study
por: Sciascia, Savino, et al.
Publicado: (2021)

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies
por: Radin, Massimo, et al.
Publicado: (2021)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Genetic Factors in Antiphospholipid Syndrome: Preliminary Experience with Whole Exome Sequencing
por: Barinotti, Alice, et al.
Publicado: (2020)

Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay
por: Sciascia, Savino, et al.
Publicado: (2016)

Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation
por: Radin, Massimo, et al.
Publicado: (2021)

IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients
por: Sciascia, Savino, et al.
Publicado: (2019)

Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients
por: Sciascia, Savino, et al.
Publicado: (2022)

Vedolizumab for the Management of Refractory Behçet’s Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease
por: Arbrile, Marta, et al.
Publicado: (2021)

Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience
por: Sciascia, Savino, et al.
Publicado: (2022)

Anti-Phosphatidylserine, Anti-Prothrombin, and Anti-Annexin V Autoantibodies in Antiphospholipid Syndrome: A Real-Life Study
por: Roselli, Daniele, et al.
Publicado: (2023)

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove
por: Sciascia, Savino, et al.
Publicado: (2021)

The “4 plus 2” rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study
por: Roccatello, Dario, et al.
Publicado: (2017)

New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing
por: Foddai, Silvia Grazietta, et al.
Publicado: (2023)

Serum Biomarkers of Renal Fibrosis: A Systematic Review
por: Barinotti, Alice, et al.
Publicado: (2022)

The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents
por: Roccatello, Dario, et al.
Publicado: (2017)

Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort
por: Roccatello, Dario, et al.
Publicado: (2017)

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab
por: Sciascia, Savino, et al.
Publicado: (2023)

Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience
por: Roccatello, Dario, et al.
Publicado: (2020)

Chasing the Zebra: a case of membranous-like Glomerulopathy with SSA/RO52 deposits and no overt connective tissue disease
por: Sciascia, Savino, et al.
Publicado: (2023)

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App
por: Radin, Massimo, et al.
Publicado: (2022)

Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet’s Disease: A Systematic Review
por: Arbrile, Marta, et al.
Publicado: (2023)

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTORApp—A Usability Study
por: Sciascia, Savino, et al.
Publicado: (2020)

Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
por: Egri, Natalia, et al.
Publicado: (2021)

Severe Multi-Organ Failure and Hypereosinophilia: When to Call It “Idiopathic”?
por: Radin, Massimo, et al.
Publicado: (2018)

The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation
por: Fabris, Martina, et al.
Publicado: (2014)

Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
por: Žigon, Polona, et al.
Publicado: (2015)

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
por: Roccatello, Dario, et al.
Publicado: (2020)

Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort
por: Mullen, Michael T., et al.
Publicado: (2012)

Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome
por: Fenoglio, Roberta, et al.
Publicado: (2018)

Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients
por: Bazzan, Mario, et al.
Publicado: (2020)

Recent advances in the management of systemic lupus erythematosus
por: Sciascia, Savino, et al.
Publicado: (2018)

Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)

Prothrombin fragment F1+2 in patients with antiphospholipid antibodies
por: Ambrozic, A, et al.
Publicado: (2004)

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE
por: Elbagir, Sahwa, et al.
Publicado: (2022)

The Role of Anti-Phosphatidylserine/Prothrombin Antibodies in Thrombotic Manifestations of Systemic Lupus Erythematosus Patients
por: Tselios, Konstantinos, et al.
Publicado: (2013)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome
por: Naranjo, Laura, et al.
Publicado: (2022)

A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
por: Roccatello, Dario, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fipf8ik4ppkeoeml1phpulaupg